Podcasts about MPH

This week is the COUNTDOWN 2025 Mega Mix.01. Pryda – Muranyi 00:00:4302. Madeon – Icarus 00:03:4303. Reza & Tom Chubb – Beggin Me To Stay 00:05:1104. Wuki – Ring of Fire 00:06:2605. John Summit ft. Julia Church & Sub Focus – Go Back (Kyle Watson Remix) 00:08:5406. MPH ft. Chris Lorenzo & EV – Run! 00:12:3107. Juos ft. Techno Tupac – Side Man 00:15:0908. Kaysin & 3Beat – Glitter and Gold 00:16:3909. Low Steppa, Rue Jay & Reza ft. Chuck Roberts – The Creator 00:19:1610. John Summit ft. rhys from the sticks & Gorgon City – Is Everybody Having Fun? 00:21:4611. Kevin De Vries – Pegasus 00:24:0112. Above & Beyond – Sun In Your Eyes 00:27:2013. Maude Vôs & Marie Nyx – Bump of Gay 00:33:2014. Madeon – All My Friends 00:34:3415. Crankdat ft. SOFI – Whiplash 00:35:1916. MPH – Raw 00:38:1617. AK SPORTS – Une Amie 00:42:0018. Pitbull – Greenlight (Gravagerz House Remix) 00:44:5419. LUCATI – Baby Baby 00:46:3520. John Summit ft. Inéz – Crystalised 00:49:2821. Above & Beyond ft. Zoë Johnston – Quicksand (Don't Go) 00:53:2122. Kaysin & Niko The Kid – What You Need 00:57:0123. southstar – Echoes 01:00:5124. AK SPORTS – Eurostar 01:03:5225. Hannah Laing x Shlomo – OMG 01:07:1026. Marie Nyx – Crimson Heart 01:10:4027. Kobosil & Ueberrest – Radiance 01:14:1328. Odymel & HARD CANDY – Fitness 01:17:5829. Kobosil & KuKO – Eiskalt 01:21:4530. DJ Heartstring & southstar – Don't Stop 01:26:0131. Clara Cuvé – 4am 01:28:0632. Cera Khin – Full Belly vs Sub Focus ft. Fireboy DML & IRAH – Original Don 01:31:4533. Shlomo & Zorza – I Wanna Feel 01:34:3334. Odymel & Funk Tribu – Forbidden Voices 01:37:1635. Gravagerz x Kiki Wera – Pool (Gravagerz Version) 01:39:0936. Cera Khin – Mamichula 01:42:0537. Wuki & Devo – Whip It 01:45:1238. Sub Focus, Culture Shock & Fragma – Miracle (VIP Mix) 01:46:4039. Hedex – Rhythm & Gash 01:49:3740. Hedex, ArrDee & Digital Farm Animals – Same Cycle 01:51:4941. Crankdat, NGHTMRE & Duke Deuce – TYPE SH-T 01:53:2642. Sub Focus ft. ARCO – Vibration (One More Time) 01:55:1143. Pryda – Allein (Album Mix) 01:57:14

Host Mati Hlatshwayo Davis, MD, MPH, FIDSA, and former CDC director Demetre Daskalakis MD, MPH, explore the current state of public health. They discuss how political pressures and weakened infrastructure have left the system vulnerable, and how this moment could spark a public health “renaissance."

On 28 September 2024, a conversation between Dr. Vivek Murthy, MD, US Surgeon General, and Sadhguru where they will explore "Loneliness: In is the Only Way Out". Hosted at the Joseph B. Martin Conference Room, Harvard Medical School, Boston, the session will be moderated by Bala Subramaniam, MD, MPH, Director of Sadhguru Center for a Conscious Planet. Set the context for a joyful, exuberant day with a short, powerful message from Sadhguru. Explore a range of subjects with Sadhguru, discover how every aspect of life can be a stepping stone, and learn to make the most of the potential that a human being embodies.  Conscious Planet: ⁠https://www.consciousplanet.org⁠ Sadhguru App (Download): ⁠https://onelink.to/sadhguru__app⁠ Official Sadhguru Website: ⁠https://isha.sadhguru.org⁠ Sadhguru Exclusive: ⁠https://isha.sadhguru.org/in/en/sadhguru-exclusive⁠ Inner Engineering Link: isha.co/ieo-podcast Yogi, mystic and visionary, Sadhguru is a spiritual master with a difference. An arresting blend of profundity and pragmatism, his life and work serves as a reminder that yoga is a contemporary science, vitally relevant to our times. Learn more about your ad choices. Visit megaphone.fm/adchoices

Fear of virologic failure is a major barrier to ensuring that people living with virally suppressed HIV are receiving the most optimal antiretroviral therapy (ART) regimen for them. Stream this Medical Minute to learn more about key guideline recommendations regarding ART switch and reassuring clinical data regarding efficacy, tolerability, and quality of life associated with switching a suppressive ART regimen. Topics covered include:Efficacy of switching to 2-drug oral ART: real-world evidenceReal-world analyses of virologic failure with switch to long-acting cabotegravir plus rilpivirinePatient selection to reduce risk of virologic failure with switch Regimen-specific switch considerationsPresenters:Dima Dandachi, MD, MPH, FIDSA, FACPAssociate Professor of MedicineDivision of Infectious DiseasesUniversity of MissouriMedical DirectorHIV Treatment and Prevention Program, MUHCMedical DirectorBoone County Public Health and Human ServicesColumbia, MissouriChloe Orkin, MBChB, FRCP, MDProfessor of Infection and InequitiesDean for Healthcare TransformationQueen Mary University of LondonFaculty of Medicine and DentistryHonorary Consultant PhysicianBarts Health NHS TrustLondon, United KingdomLink to full program and accompanying slides:https://bit.ly/3KPN0xbGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

On 28 September 2024, a conversation between Dr. Vivek Murthy, MD, US Surgeon General, and Sadhguru where they will explore "Loneliness: In is the Only Way Out". Hosted at the Joseph B. Martin Conference Room, Harvard Medical School, Boston, the session will be moderated by Bala Subramaniam, MD, MPH, Director of Sadhguru Center for a Conscious Planet. Set the context for a joyful, exuberant day with a short, powerful message from Sadhguru. Explore a range of subjects with Sadhguru, discover how every aspect of life can be a stepping stone, and learn to make the most of the potential that a human being embodies.  Conscious Planet: ⁠https://www.consciousplanet.org⁠ Sadhguru App (Download): ⁠https://onelink.to/sadhguru__app⁠ Official Sadhguru Website: ⁠https://isha.sadhguru.org⁠ Sadhguru Exclusive: ⁠https://isha.sadhguru.org/in/en/sadhguru-exclusive⁠ Inner Engineering Link: isha.co/ieo-podcast Yogi, mystic and visionary, Sadhguru is a spiritual master with a difference. An arresting blend of profundity and pragmatism, his life and work serves as a reminder that yoga is a contemporary science, vitally relevant to our times. Learn more about your ad choices. Visit megaphone.fm/adchoices

About this episode: As hesitancy about human vaccines rises, so too does skepticism of routine pet immunizations. In this episode: Veterinarians Meghan Davis and Kaitlin Waite explain what's behind growing anti-vaccine sentiment among pet owners, how veterinarians are navigating this divide, and why an understanding of the human-animal bond can yield better public health outcomes for all. Guests: Meghan Davis, PhD, MPH, DVM, is a veterinarian and public health researcher at the Johns Hopkins Bloomberg School of Public Health with a joint appointment at the School of Medicine. Kaitlin Waite, MPH, DVM, is a veterinarian and a postdoctoral fellow at the Johns Hopkins Bloomberg School of Public Health, where she also serves as the Deputy Director of Outreach Core at the POE Center. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs. Show links and related content: Here's Why Fewer People Are Vaccinating Their Pets—TIME Vaccine Skepticism Comes for Pet Owners, Too—New York Times The importance of vaccinating your pet—Virginia-Maryland College of Veterinary Medicine Could One Health Prevent the Next Pandemic?—Public Health On Call (September 2025) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

In this episode, hosts Blake Williamson, MD, MPH, and Gary Wörtz, MD, invite Kenneth Beckman, MD, to discuss the recent FDA approval of Epioxa (Glaukos), an advancement in corneal crosslinking for the treatment of keratoconus that does not require the removal of the corneal epithelium. Dr. Beckman shares insights into the benefits and outcomes of this procedure and details from clinical trials.

BT & Sal kick off the segment with a mix of disgust and fascination over football player Cam Skattebo's latest viral stunt: chugging an energy drink from his cleat (a "Shoey"). Then, they dive into a fiery hypothetical: an Athletic-proposed trade for Tigers ace Tarik Skubal involving a Yankees package of Spencer Jones, Will Warren, and two pitching prospects. The hosts debate whether this offer is deliberately undervaluing Skubal compared to the Mets' reported trade pieces, reigniting the argument over the true quality of the Yankees' farm system. The conversation shifts to the upcoming Japanese posting window, with Sal confidently predicting the Mets and Yankees will each land a star, while Tierney is skeptical, fearing the Dodgers will collect everyone. They discuss the worrying scouting report on star hitter Munetaka Murakami and his inability to hit fastballs over 93 MPH. The segment wraps up by venting about high NBA ticket prices and the outrage fans feel when high-priced stars like Giannis sit out.

Join host and HRS Digital Education Committee Member Melissa Middeldorp, MPH, PhD and her guests Rod Passman, MD, FHRS, and Emma Svenberg, MD, PhD, live at HRX 2025. In this episode, we explore the AMALFI Randomized Clinical Trial, which evaluated whether remote, wearable-based screening can effectively detect asymptomatic atrial fibrillation in high-risk adults. The discussion breaks down the study design, key findings, and implications for population-level AF screening strategies. It also examines how emerging digital health tools may integrate into routine cardiovascular prevention.    Learning Objectives Describe the design, patient population, and primary outcomes of the AMALFI Randomized Clinical Trial. Evaluate the effectiveness of remote wearable monitoring compared with usual care for detecting asymptomatic atrial fibrillation. Discuss the potential clinical and health-system implications of implementing large-scale remote AF screening in high-risk populations.   Article Authors Rohan Wijesurendra, DPhil, Guilherme Pessoa-Amorim, DPhil, Georgina Buck, MSc,Charlie Harper, DPhil, Richard Bulbulia, MD, Alison Offer, PhD, Nicholas R. Jones, DPhil, Christine A'Court, MA, Rijo Kurien, MSc, Karen Taylor, MSc, Barbara Casadei, DPhil, Louise Bowman, MD.   Podcast Contributors Melissa E. Middeldorp, MPH, PhD Rod S. Passman, MD, FHRS Emma Svennberg, MD, PhD   Article for Discussion  

In this podcast episode, Paul Limburg, MD, MPH, discusses the movement from academics to industry, developments in colorectal cancer screening tools and more. •    Intro 1:11 •    Paul Limburg, MD, MPH  1:17 •    How did your early influences and childhood years lead you to become interested in gastroenterology and the career you have today?  1:34 •    Who were your early inspirations?  2:14 •    How did you transition from a career in academics and sciences to a life on the commercial side? 3:34 •    How did your role at Exact Sciences come about? 5:58 •    Was it a hard decision to take a new position? 7:47 •    Chey and Limburg on the joy of advancing science and innovation. 9:03 •    Were there any cultural differences that shocked you about the ways work is done in your previous and current positions? 10:10  •    Do you see Exact outsourcing scientific research as the company grows? 12:12 •    What does a typical day look like for you at Exact? […] What are you responsible of as the leading physician? 13:28 •    From a product standpoint, what is ahead on the roadmap for Exact Sciences? […] What are you most excited about regarding next-generation multi-target stool testing and its impact? 15:14 •    How do you respond to gastroenterologists' skepticism and concerns surrounding stool-based screening? 21:15 •    What about addressing the concerns surrounding how we can ensure patients with a positive FIT test go in for a colonoscopy? 23:22 •    How much of an issue are language barriers when it comes to screening tools? 28:11 •    Can you talk about how Exact Sciences are using AI and the evolution of the microbiome internally or in product development? 29:42 •    Do you see a future for stool-based testing in between/in combination with colonoscopies? 32:59 •    Have you noticed differences in sensitivity and specificity based on age? 34:07 •    What are your thoughts on making these tools available in a direct-to-consumer offering? […] How do you make these screening tools more readily available while weighing the usage risks? 35:08 •    What is the rate of patients who have a positive stool-based test getting a colonoscopy? 38:44 •    If you were talking to a GI fellow deciding to make the jump to industry, what do you tell them? 41:58 •    Thank you, Paul 44:55 •    Thanks for listening 45:21 Paul J. Limburg, MD, MPH, is chief medical officer for screening at Exact Sciences and emeritus professor of Medicine at Mayo Clinic.     We'd love to hear from you! Send your comments/questions to guttalkpodcast@healio.com. Follow us on X @HealioGastro @sameerkberry @umfoodoc. For more from Dr. Limburg, follow @limburg_paul and @ExactSciences on X. Disclosures: Chey and Berry report no relevant financial disclosures. Limburg reports he is an employee of Exact Sciences.

You've done the meal prep, the steps, the Peloton rides after bedtime stories—yet the scale is not "scaling". Now everybody from your group chat to Serena Williams is talking about “the shot.” In this episode, Dr. Stephane Hack, MD, MPH, breaks down GLP-1 medications (like Ozempic, Wegovy, and Zepbound) in plain language: what they are, how they work, who they're really for, and what risks often get glossed over. We'll talk motherhood, metabolism, perimenopause, endometriosis, fertility, and the pressure to “snap back". Whether you're a busy professional juggling work, marriage, kids, or just trying to feel at home in your own body again, this conversation is your judgment-free zone to get informed before you decide what's next for your body.

In this episode of ACEP Nowcast, host Amy Faith Ho, MD, MPH, FACEP, interviews Nirajan Nepal, MD, to discuss pulmonary embolism after routine peripheral intravenous catheter insertion, and reminds us that routine is only routine until it is not. We also touch on life in military medicine. Read the full case report at ACEPNow.com. More links: Read more on ACEPNow.com. Revisit ACEP Nowcast podcast episodes.  View job opportunities at emCareers.

Co-hosts Ryan Piansky, a graduate student and patient advocate living with eosinophilic esophagitis (EoE) and eosinophilic asthma, and Holly Knotowicz, a speech-language pathologist living with EoE who serves on APFED's Health Sciences Advisory Council, interview Evan S. Dellon, MD, and Elizabeth T. Jensen, PhD, about a paper they published on predictors of patients receiving no medication for treatment of eosinophilic esophagitis. Disclaimer: The information provided in this podcast is designed to support, not replace, the relationship between listeners and their healthcare providers. Opinions, information, and recommendations shared in this podcast are not a substitute for medical advice. Decisions related to medical care should be made with your healthcare provider. Opinions and views of guests and co-hosts are their own.   Key Takeaways: [:52] Co-host Ryan Piansky introduces the episode, brought to you thanks to the support of Education Partners GSK, Sanofi, Regeneron, and Takeda. Ryan introduces co-host Holly Knotowicz.   [1:14] Holly introduces today's topic, predictors of not using medication for EoE, and today's guests, Dr. Evan Dellon and Dr. Elizabeth Jensen.   [1:29] Dr. Dellon is an Adjunct Professor of Epidemiology at the University of North Carolina School of Medicine in Chapel Hill. He is also the Director of the UNC Center for Esophageal Diseases and Swallowing.   [1:42] Dr. Dellon's main research interest is in the epidemiology, pathogenesis, diagnosis, treatment, and outcomes of eosinophilic esophagitis (EoE) and eosinophilic GI diseases (EGIDs).   [1:55] Dr. Jensen is a Professor of Epidemiology with a specific expertise in reproductive, perinatal, and pediatric epidemiology. She has appointments at both Wake Forest University School of Medicine and the University of North Carolina at Chapel Hill.   [2:07] Her research primarily focuses on etiologic factors in the development of pediatric immune-mediated chronic diseases, including understanding factors contributing to disparities in health outcomes.   [2:19] Both Dr. Dellon and Dr. Jensen also serve on the Steering Committee for EGID Partners Registry.   [2:24] Ryan thanks Dr. Dellon and Dr. Jensen for joining the podcast today.   [2:29] Dr. Dellon was the first guest on this podcast. It is wonderful to have him back for the 50th episode! Dr. Dellon is one of Ryan's GI specialists. Ryan recently went to North Carolina to get a scope with him.   [3:03] Dr. Dellon is an adult gastroenterologist at the University of North Carolina at Chapel Hill. He directs the Center for Esophageal Diseases and Swallowing. Clinically and research-wise, he is focused on EoE and other eosinophilic GI diseases.   [3:19] His research interests span the entire field, from epidemiology, diagnosis, biomarkers, risk factors, outcomes, and a lot of work, more recently, on treatments.   [3:33] Dr. Jensen has been on the podcast before, on Episode 27. Holly invites Dr. Jensen to tell the listeners more about herself and her work with eosinophilic diseases.   [3:46] Dr. Jensen has been working on eosinophilic gastrointestinal diseases for about 15 years. She started some of the early work around understanding possible risk factors for the development of disease.   [4:04] She has gone on to support lots of other research projects, including some with Dr. Dellon, where they're looking at gene-environment interactions in relation to developing EoE.   [4:15] She is also looking at reproductive factors as they relate to EoE, disparities in diagnosis, and more. It's been an exciting research trajectory, starting with what we knew very little about and building to an increasing understanding of why EoE develops.   [5:00] Dr. Dellon explains that EoE stands for eosinophilic esophagitis, a chronic allergic condition of the esophagus.   [5:08] You can think of EoE as asthma of the esophagus or eczema of the esophagus, although in general, people don't grow out of EoE, like they might grow out of eczema or asthma. When people have EoE, it is a long-term condition.   [5:24] Eosinophils are a type of white blood cell, specializing in allergy responses. Normally, they are not in the esophagus. When we see them there, we worry about an allergic process. When that happens, that's EoE.   [5:40] Over time, the inflammation seen in EoE and other allergic cell activity causes swelling and irritation in the esophagus. Early on, this often leads to a range of upper GI symptoms — including poor growth or failure to thrive in young children, abdominal pain, nausea, and symptoms that can mimic reflux.   [5:58] In older kids, symptoms are more about trouble swallowing. That's because the swelling that happens initially, over time, may turn into scar tissue. So the esophagus can narrow and cause swallowing symptoms like food impaction.   [6:16] Ryan speaks of living with EoE for decades and trying the full range of treatment options: food elimination, PPIs, steroids, and, more recently, biologics.   [6:36] Dr. Dellon says Ryan's history is a good overview of how EoE is treated. There are two general approaches to treating the underlying condition: using medicines and/or eliminating foods that we think may trigger EoE from the diet.   [6:57] For a lot of people, EoE is a food-triggered allergic condition.   [7:01] The other thing that has to happen in parallel is surveying for scar tissue in the esophagus. If that's present and people have trouble swallowing, sometimes stretching the esophagus is needed through esophageal dilation.   [7:14] There are three categories of medicines used for treatment. Proton pump inhibitors are reflux meds, but they also have an anti-allergy effect in the esophagus.   [7:29] Topical steroids are used to coat the esophagus and produce an anti-inflammatory effect. The FDA has approved a budesonide oral suspension for that.   [7:39] Biologics, which are generally systemic medications, often injectable, can target different allergic factors. Dupilumab is approved now, and there are other biologics that are being researched as potential treatments.   [7:51] Even though EoE is considered an allergic condition, we don't have a test to tell people what they are allergic to. If it's a food allergy, we do an empiric elimination diet because allergy tests aren't accurate enough to tell us what the EoE triggers are.   [8:10] People will eliminate foods that we know are the most common triggers, like milk protein, dairy, wheat, egg, soy, and other top allergens. You can create a diet like that and then have a response to the diet elimination.   [8:31] Dr. Jensen and Dr. Dellon recently published an abstract in the American Journal of Gastroenterology about people with EoE who are not taking any medicine for it. Dr. Jensen calls it a real-world data study, leveraging electronic health record patient data.   [8:51] It gives you an impression of what is actually happening, in terms of treatments for patients, as opposed to a randomized control trial, which is a fairly selected patient population. This is everybody who has been diagnosed, and then what happens with them.   [9:10] Because of that, it gives you a wide spectrum of patients. Some patients are going to be relatively asymptomatic. It may be that we arrived at their diagnosis while working them up for other potential diagnoses.   [9:28] Other patients are going to have rather significant impacts from the disease. We wanted to get an idea of what is actually happening out there with the full breadth of the patient population that is getting diagnosed with EoE.   [9:45] Dr. Jensen was not surprised to learn that there are patients who had no pharmacologic treatment.   [9:58] Some patients are relatively asymptomatic, and others are not interested in pursuing medications initially or are early in their disease process and still exploring dietary treatment options.   [10:28] Holly sees patients from infancy to geriatrics, and if they're not having symptoms, they wonder why bother treating it.   [10:42] Dr. Jensen says it's a point of debate on the implications of somebody who has the disease and goes untreated. What does that look like long-term? Are they going to develop more of that fibrostenotic pattern in their esophagus without treatment?   [11:07] This is a question we're still trying to answer. There is some suggestion that for some patients who don't manage their disease, we very well may be looking at a food impaction in the future.   [11:19] Dr. Dellon says we know overall for the population of EoE patients, but it's hard to know for a specific patient. We have a bunch of studies now that look at how long people have symptoms before they're diagnosed. There's a wide range.   [11:39] Some people get symptoms and get diagnosed right away. Others might have symptoms for 20 or 30 years that they ignore, or don't have access to healthcare, or the diagnosis is missed.   [11:51] What we see consistently is that people who may be diagnosed within a year or two may only have a 10 or 20% chance of having that stricture and scar tissue in the esophagus, whereas people who go 20 years, it might be 80% or more.   [12:06] It's not everybody who has EoE who might end up with that scar tissue, but certainly, it's suggested that it's a large majority.   [12:16] That's before diagnosis. We have data that shows that after diagnosis, if people go a long time without treatment or without being seen in care, they also have an increasing rate of developing strictures.    [12:29] In general, the idea is yes, you should treat EoE, because on average, people are going to develop scar tissue and more symptoms. For the patient in front of you with EoE but no symptoms, what are the chances it's going to get worse? You don't know.   [13:04] There are two caveats with that. The first is what we mean by symptoms. Kids may have vomiting and growth problems. Adults can eat carefully, avoiding foods that hang up in the esophagus, like breads and overcooked meats, sticky rice, and other foods.   [13:24] Adults can eat slowly, drink a lot of liquid, and not perceive they have symptoms. When someone tells Dr. Dellon they don't have symptoms, he will quiz them about that. He'll even ask about swallowing pills.    [13:40] Often, you can pick up symptoms that maybe the person didn't even realize they were having. In that case, that can give you some impetus to treat.   [13:48] If there really are no symptoms, Dr. Dellon thinks we're at a point where we don't really know what to do.   [13:54] Dr. Dellon just saw a patient who had a lot of eosinophils in their small bowel with absolutely no GI symptoms. He said, "I can't diagnose you with eosinophilic enteritis, but you may develop symptoms." People like that, he will monitor in the clinic.   [14:14] Dr. Dellon will discuss it with them each time they come back for a clinic visit.   [14:19] Holly is a speech pathologist, but also sees people for feeding and swallowing. The local gastroenterologist refers patients who choose not to treat their EoE to her. Holly teaches them things they should be looking out for.   [14:39] If your pills get stuck or if you're downing 18 ounces during a mealtime, maybe it's time to treat it. People don't see these coping mechanisms they use that are impacting their quality of life. They've normalized it.   [15:30] Dr. Dellon says, of these people who aren't treated, there's probably a subset who appropriately are being observed and don't have a medicine treatment or are on a diet elimination.   [15:43] There's also probably a subset who are inappropriately not on treatment. It especially can happen with students who were under good control with their pediatric provider, but moved away to college and didn't transfer to adult care.   [16:08] They ultimately come back with a lot of symptoms that have progressed over six to eight years.   [16:18] Ryan meets newly diagnosed adult patients at APFED's conferences, who say they have no symptoms, but chicken gets caught in their throat. They got diagnosed when they went to the ER with a food impaction.   [16:38] Ryan says you have to wonder at what point that starts to get reflected in patient charts. Are those cases documented where someone is untreated and now has EoE?   [16:49] Ryan asks in the study, "What is the target EGID Cohort and why was it selected to study EoE? What sort of patients were captured as part of that data set?"   [16:58] Dr. Jensen said they identified patients with the ICD-10 code for a diagnosis of EoE. Then they looked to see if there was evidence of symptoms or complications in relation to EoE. This was hard; some of these are relatively non-specific symptoms.   [17:23] These patients may have been seeking care and may have been experiencing some symptoms that may or may not have made it into the chart. That's one of the challenges with real-world data analyses.   [17:38] Dr. Jensen says they are using data that was collected for documenting clinical care and for billing for clinical care, not for research, so it comes with some caveats when doing research with this data.   [18:08] Research using electronic health records gives a real-world perspective on patients who are seeking care or have a diagnosis of EoE, as opposed to a study trying to enroll a patient population that potentially isn't representative of the breadth of individuals living with EoE.   [18:39] Dr. Dellon says another advantage of real-world data is the number of patients. The largest randomized controlled trials in EoE might have 400 patients, and they are incredibly expensive to do.   [18:52] A study of electronic health records (EHR) is reporting on the analysis of just under 1,000. The cohort, combined from three different centers, has more than 1,400 people, a more representative, larger population.    [19:16] Dr. Dellon says when you read the results, understand the limitations and strengths of a study of health records, to help contextualize the information.   [19:41] Dr. Dellon says it's always easier to recognize the typical presentations. Materials about EoE and studies he has done that led to medicine approvals have focused on trouble swallowing. That can be relatively easily measured.   [20:01] Patients often come to receive care with a food impaction, which can be impactful on life, and somewhat public, if in a restaurant or at work. Typical symptoms are also the ones that get you diagnosed and may be easier to treat.   [20:26] Dr. Dellon wonders if maybe people don't treat some of the atypical symptoms because it's not appreciated that they can be related to EoE.   [20:42] Holly was diagnosed as an adult. Ryan was diagnosed as a toddler. Holly asks what are some of the challenges people face in getting an EoE diagnosis.   [20:56] Dr. Jensen says symptoms can sometimes be fairly non-specific. There's some ongoing work by the CEGIR Consortium trying to understand what happens when patients come into the emergency department with a food bolus impaction.   [21:28] Dr. Jensen explains that we see there's quite a bit of variation in how that gets managed, and if they get a biopsy. You have to have a biopsy of the esophagus to get a diagnosis of EoE.   [21:45] If you think about the steps that need to happen to get a diagnosis of EoE, that can present barriers for some groups to ultimately get that diagnosis.   [21:56] There's also been some literature around a potential assumption about which patients are more likely to be at risk. Some of that is still ongoing. We know that EoE occurs more commonly in males in roughly a two-to-one ratio. Not exclusively in males, obviously, but a little more often in males.   [22:20] We don't know anything about other groups of patients that may be at higher risk. That's ongoing work that we're still trying to understand. That in itself can also be a barrier when there are assumptions about who is or isn't likely to have EoE.   [23:02] Dr. Dellon says that in adolescents and adults, the typical symptoms are trouble swallowing and food sticking, which have many causes besides EoE, some of which are more common.   [23:18] In that population, heartburn is common. Patients may report terrible reflux that, on questioning, sounds more like trouble swallowing than GERD. Sometimes, with EoE, you may have reflux that doesn't improve. Is it EoE, reflux, or both?   [24:05] Some people will have chest discomfort. There are some reports of worsening symptoms with exercise, which brings up cardiac questions that have to be ruled out first.   [24:19] Dr. Dellon mentions some more atypical symptoms. An adult having pain in the upper abdomen could have EoE. In children, the symptoms could be anything in the GI tract. Some women might have atypical symptoms with less trouble swallowing.   [24:58] Some racial minorities may have those kinds of symptoms, as well. If you're not thinking of the condition, it's hard to make the diagnosis.   [25:08] Dr. Jensen notes that there are different cultural norms around expressing symptoms and dietary patterns, which may make it difficult to parse out a diagnosis.   [25:27] Ryan cites a past episode where access to a GI specialist played a role in diagnosing patients with EoE. Do white males have more EoE, or are their concerns just listened to more seriously?   [25:57] Ryan's parents were told when he was two that he was throwing up for attention. He believes that these days, he'd have a much easier time convincing a doctor to listen to him. From speaking to physicians, Ryan believes access is a wide issue in the field.   [26:23] Dr. Dellon tells of working with researchers at Mayo in Arizona and the Children's Hospital of Phoenix. They have a large population of Hispanic children with EoE, much larger than has been reported elsewhere. They're working on characterizing that.   [26:49] Dr. Dellon describes an experience with a visiting trainee from Mexico City, where there was not a lot of EoE reported. The trainee went back and looked at the biopsies there, and it turned out they were not performing biopsies on patients with dysphagia in Mexico City.   [27:13] When he looked at the patients who ended up getting biopsies, they found EoE in 10% of patients. That's similar to what's reported out of centers in the developed world. As people are thinking about it more, we will see more detection of it.   [27:30] Dr. Dellon believes those kinds of papers will be out in the next couple of months, to a year.   [27:36] Holly has had licensure in Arizona for about 11 years. She has had nine referrals recently of children with EoE from Arizona. Normally, it's been one or two that she met at a conference.   [28:00] Ryan asks about the research on patients not having their EoE treated pharmacologically. Some treat it with food avoidance and dietary therapy. Ryan notes that he can't have applesauce, as it is a trigger for his EoE.   [28:54] Dr. Jensen says that's one of the challenges in using the EHR data. That kind of information is only available to the researchers through free text. That's a limitation of the study, assessing the use of dietary elimination approaches.   [29:11] Holly says some of her patients have things listed as allergies that are food sensitivities. Ryan says it's helpful for the patients to have their food sensitivities listed along with their food allergies, but it makes records more difficult to parse for research.   [30:14] Dr. Dellon says they identify EoE by billing code, but the codes are not always used accurately. Natural Language Processing can train a computer system to find important phrases. Their collaborators working on the real-world data are using it.   [30:59] Dr. Dellon hopes that this will be a future direction for this research to find anything in the text related to diet elimination.   [31:32] Dr. Jensen says that older patients were less likely to seek medication therapy. She says it's probably for a couple of reasons. First, older patients may have been living with the disease for a long time and have had compensatory mechanisms in place.   [32:03] The other reason may be senescence or burnout of the disease, long-term. Patients may be less symptomatic as they get older. That's a question that remains to be answered for EoE. It has been seen in some other disease processes.   [32:32] Dr. Dellon says there's not much data specifically looking at EoE in the older population. Dr. Dellon did work years ago with another doctor, and they found that older patients had a better response to some treatments, particularly topical steroids.   [32:54] It wasn't clear whether it was a milder aspect of the disease, easier to treat, or because they were older and more responsible, taking their medicines as prescribed, and having a better response rate. It's the flip side of work in the pediatric population.   [33:16] There is an increasingly aging population with EoE. Young EoE patients will someday be over 65. Dr. Dellon hopes there will be a cure by that point, but it's an expanding population now.   [33:38] Dr. Jensen says only a few sites are contributing data, so they hope to add additional sites to the study. For some of the less common outcomes, they need a pretty large patient sample to ask some of those kinds of questions.   [33:55] They will continue to follow up on some of the work that this abstract touched on and try to understand some of these issues more deeply.   [34:06] Dr. Dellon mentions other work within the cohort. Using Natural Language Processing, they are looking at characterizing endoscopy information and reporting it without a manual review of reports and codes. You can't get that from billing data.   [34:29] Similarly, they are trying to classify patient severity by the Index of Severity with EoE, and layer that on looking at treatments and outcomes based on disease severity. Those are a couple of other directions where this cohort is going.   [34:43] Holly mentions that this is one of many research projects Dr. Jensen and Dr. Dellon have collaborated on together. They also collaborate through EGID Partners. Holly asks them to share a little bit about that.   [34:53] Dr. Jensen says EGID Partners is an online registry where individuals, caregivers, and parents of children affected with EGIDs can join.   [35:07] EGID Partners also needs people who don't live with an EGID to join, as controls. That gives the ability to compare those who are experiencing an EGID relative to those who aren't.   [35:22] When you join EGID Partners, they provide you with a set of questionnaires to complete. Periodically, they push out a few more questionnaires.   [35:33] EGID Partners has provided some really great information about patient experience and answered questions that patients want to know about, like joint pain and symptoms outside the GI tract.   [36:04] To date, there are close to 900 participants in the registry from all over the world. As it continues to grow, it will give the ability to look at the patient experience in different geographical areas.   [36:26] Dr. Dellon says we try to have it be interactive, because it is a collaboration with patients. The Steering Committee works with APFED and other patient advocacy groups from around the world.    [36:41] The EGID Partners website shows general patient locations anonymously. It shows the breakdown of adults with the condition and caregivers of children with the condition, the symptom distribution, and the treatment distribution.   [37:03] As papers get published and abstracts are presented, EGID Partners puts them on the website. Once someone joins, they can suggest a research idea. Many of the studies they have done have come from patient suggestions.   [37:20] If there's an interesting idea for a survey, EGID Partners can push out a survey to everybody in the group and answer questions relatively quickly.   [37:57] Dr. Dellon says a paper came out recently about telehealth. EoE care, in particular, is a good model for telehealth because it can expand access for patients who don't have providers in their area.   [38:22] EoE is a condition where care involves a lot of discussion but not a lot of need for physical exams and direct contact, so telehealth can make things very efficient.    [38:52] EGID Partners surveyed patients about telehealth. They thought it was efficient and saved time, and they had the same kind of interactions as in person. In general, in-state insurance covered it. Patients were happy to do those kinds of visits again.   [39:27] Holly says Dr. Furuta, herself, and others were published in the Gastroenterology journal in 2019 about starting to do telehealth because patients coming to the Children's Hospital of Colorado from out of state had no local access to feeding therapy.   [39:50] Holly went to the board, and they allowed her to get licensure in different states. She started with some of the most impacted patients in Texas and Florida in 2011 and 2012. They collected data. They published in 2019 about telehealth's positive impact.   [40:13] When 2020 rolled around, Holly had trained a bunch of people on how to do feeding therapy via telehealth. You have to do all kinds of things, like make yourself disappear, to keep the kids engaged and in their chairs!   [40:25] Now it is Holly's primary practice. She has licenses in nine states. She sees people all over the country. With her diagnosis, her physicians at Mass General have telehealth licensure in Maine. She gets to do telehealth with them instead of driving two hours.   [40:53] Dr. Jensen tells of two of the things they hope to do at EGID Partners. One is trying to understand more about reproductive health for patients with an EGID diagnosis. Only a few studies have looked at this question, and with very small samples.   [41:15] As more people register for EGID Partners, Dr. Jensen is hoping to be able to ask some questions related to reproductive health outcomes.   [41:27] The second goal is a survey suggested by the Student Advisory Committee, asking questions related to the burden of disease specific to the teen population.   [41:48] This diagnosis can hit that population particularly hard, at a time when they are trying to build and sustain friendships and are transitioning to adult care and moving away from home. This patient population has a unique perspective we wanted to hear.   [42:11] Dr. Jensen and Dr. Dellon work on all kinds of other projects, too.   [42:22] Dr. Dellon says they have done a lot of work on the early-life factors that may predispose to EoE. They are working on a large epidemiologic study to get some insight into early-life factors, including factors that can be measured in baby teeth.   [42:42] That's outside of EGID Partners. It's been ongoing, and they're getting close, maybe over the next couple of years, to having some results.   [43:03] Ryan says all of those projects sound so interesting. We need to have you guys back to dive into those results when you have something finalized.   [43:15] For our listeners who want to learn more about eosinophilic disorders, we encourage you to visit apfed.org and check out the links in the show notes below.   [43:22] If you're looking to find specialists who treat eosinophilic disorders, we encourage you to use APFED's Specialist Finder at apfed.org/specialist.   [43:31] If you'd like to connect with others impacted by eosinophilic diseases, please join APFED's online community on the Inspire Network at apfed.org/connections.   [43:41] Ryan thanks Dr. Dellon and Dr. Jensen for joining us today. This was a fantastic conversation. Holly also thanks APFED's Education Partners GSK, Sanofi, Regeneron, and Takeda for supporting this episode.   Mentioned in This Episode: Evan S. Dellon, MD, MPH, Academic Gastroenterologist, University of North Carolina School of Medicine   Elizabeth T. Jensen, MPH, PhD, Epidemiologist, Wake Forest University School of Medicine, University of North Carolina at Chapel Hill   Predictors of Patients Receiving No Medication for Treatment of Eosinophilic Esophagitis in the United States: Data from the TARGET-EGIDS Cohort   Episode 15: Access to Specialty Care for Eosinophilic Esophagitis (EoE)   APFED on YouTube, Twitter, Facebook, Pinterest, Instagram Real Talk: Eosinophilic Diseases Podcast apfed.org/specialist apfed.org/connections apfed.org/research/clinical-trials   Education Partners: This episode of APFED's podcast is brought to you thanks to the support of GSK, Sanofi, Regeneron, and Takeda.   Tweetables:   "I've been working on eosinophilic gastrointestinal diseases for about 15 years. I started some of the early work around understanding possible risk factors for the development of disease. I've gone on to support lots of other research projects." — Elizabeth T. Jensen, MPH, PhD   "You can think of EoE as asthma of the esophagus or eczema of the esophagus, although in general, people don't grow out of EoE, like they might grow out of eczema or asthma. When people have it, it really is a long-term condition." — Evan S. Dellon, MD, MPH   "There are two general approaches to treating the underlying condition, … using medicines and/or eliminating foods from the diet that we think may trigger EoE. I should say, for a lot of people, EoE is a food-triggered allergic condition." — Evan S. Dellon, MD, MPH   "I didn't find it that surprising [that there are patients who had no treatment]. Some patients are relatively asymptomatic, and others are not interested in pursuing medications initially or are … still exploring dietary treatment options." — Elizabeth T. Jensen, MPH, PhD   "We have a bunch of studies now that look at how long people have symptoms before they're diagnosed. There's a wide range. Some people get symptoms and are diagnosed right away. Other people might have symptoms for 20 or 30 years." — Evan S. Dellon, MD, MPH   "EGID Partners is an online registry where individuals, caregivers, and parents of children affected with EGIDs can join. EGID Partners also needs people who don't live with an EGID to join, as controls." — Elizabeth T. Jensen, MPH, PhD

In this episode of New Frontiers in Functional Medicine, Dr. Kara Fitzgerald sits down with hormone and women's health expert Dr. Carrie Jones to explore the powerful connection between mitochondrial health and women's hormones. Together, they unpack how mitochondrial function influences hormone balance, metabolism, energy, mood, and resilience, especially during perimenopause and menopause. Dr. Jones shares practical, evidence-based strategies to support mitochondrial health for optimal hormonal balance, improved sleep, and emotional well-being. Listeners will gain actionable insights into functional medicine approaches to women's hormone health, including how mitochondrial vitality can help ease hormonal transitions and enhance longevity. Check out the show notes at https://www.drkarafitzgerald.com/fxmed-podcast/ for the full list of links and resources. GUEST DETAILS Dr. Carrie Jones, ND, FABNE, MPH, MSCP is an internationally recognized expert in women's health and hormones. Known as the “Queen of Hormones,” she's a naturopathic physician, educator, and Chief Medical Officer at NuEthix Formulations. With over 20 years in the field, Dr. Jones has shaped hormone education through her work with major functional labs and her hit podcast, Hello Hormones. Email: drjones@drcarriejones.com Website: https://www.drcarriejones.com/ THANKS TO OUR SPONSORS DIAMOND DUTCH: https://dutchtest.com/for-providers Biotics Research: https://bit.ly/2IHK6Xd GOLD TimeLine Nutrition: https://tinyurl.com/bdzx2xms Vibrant Wellness: https://www.vibrant-wellness.com/ EXCLUSIVE OFFERS FROM OUR SPONSORS OneSkin: Get 15% off OneSkin with the code DRKARA at http://oneskin.co/DRKARA Find out why MitoQ's mitochondria-targeting is a critical step for your healthspan and longevity strategy. https://tinyurl.com/4f8t7jt6 *CONNECT with DrKF* Want more? Join our newsletter here: https://www.drkarafitzgerald.com/newsletter/ Or take our pop quiz and test your BioAge! https://www.drkarafitzgerald.com/bioagequiz YouTube: https://tinyurl.com/hjpc8daz Instagram: https://www.instagram.com/drkarafitzgerald/ Facebook: https://www.facebook.com/DrKaraFitzgerald/ DrKF Clinic: Patient consults with DrKF physicians including Younger You Concierge: https://tinyurl.com/yx4fjhkb Younger You Practitioner Training Program: www.drkarafitzgerald.com/trainingyyi/ Younger You book: https://tinyurl.com/mr4d9tym Better Broths and Healing Tonics book: https://tinyurl.com/3644mrfw

We welcome one of the leading experts in reversing deforestation worldwide. Dr. Kinari Webb is a medical doctor whose work on multiple continents has helped improve the lives of people and the environments in which they live. By making health care affordable for people in rainforest villages, she has helped reduce illegal logging, which was a source of income for some patients. A healthier rainforest, in turn, has made for healthier people. As she explains in her TEDx talk, she's saving lives by saving trees. For the second time, the Seneca Park Zoo Society is bestowing its Conservation Warrior Award; it has selected Dr. Webb as the winner. We discuss the impact that Webb's work has had abroad and on conservationists in western New York. Our guests: Kinari Webb, M.D., founder of Health In Harmony Pamela Reed Sanchez, president and CEO of the Seneca Park Zoo Society Jeff Wyatt, DVM, MPH, professor and chair of comparative medicine at the University of Rochester School of Medicine and Dentistry ---Connections is supported by listeners like you. Head to our donation page to become a WXXI member today, support the show, and help us close the gap created by the rescission of federal funding.---Connections airs every weekday from noon-2 p.m. Join the conversation with questions or comments by phone at 1-844-295-TALK (8255) or 585-263-9994, email, Facebook or Twitter. Connections is also livestreamed on the WXXI News YouTube channel each day. You can watch live or access previous episodes here.---Do you have a story that needs to be shared? Pitch your story to Connections.

Whether you're looking for hope, practical advocacy tips, or updates on current legislation, you'll find inspiration in how collective action—powered by real stories—can fuel progress. Stay tuned for an uplifting, honest, and actionable conversation that's helping shape the future of women's health. This episode with Liz Powell, hosted by Lisa Malia covers timely topics like the FDA's recent announcement about hormone therapy, the vital work of the Breast Cancer Early Detection Coalition, and accessible ways anyone can join the movement for better health outcomes. TIMESTAMPS: 00:00 Women's Health Advocacy Network 05:28 Holistic Women's Health Advocacy 08:21 "Empowerment Through Advocacy Stories" 09:49 Hormone Therapy Misunderstood in WHI 15:43 Staying Hopeful Amid Overwhelm 17:09 "Easy Steps to Advocacy" 19:56 "Change Starts Within Us" 23:26 "2024: Women's Health Revolution" 28:49 Supplemental Breast Cancer Screening 30:30 "Fighting for Double Mastectomy" 36:19 Advocacy Secures Funding Success 39:52 "Open, Agile, Impactful Leadership" 41:26 "Grateful to Be Involved"   LEARN MORE:  The Clear Pathways Program: https://www.breastdensitysummit.org/ The Breast Density Summit: https://www.breastdensitysummit.org/webinar-registration MAKE A DONATION: https://www.paypal.com/donate?hosted_button_id=NJMF86A8Y9RJQ Follow LISA MALIA LinkedIn: https://www.linkedin.com/in/lisamalianorman/   WOMEN'S HEALTH ADVOCATES: https://womenshealthadvocates.org/ BREAST CANCER EARLY DETECTION COALITION: https://womenshealthadvocates.org/bcedc/ G2G CONSULTING: https://www.g2gconsulting.com Follow LIZ POWELL LinkedIn: https://www.linkedin.com/in/liz-powell-507b135/   Liz is Founder of G2G Consulting, which creates and implements government to growth (G2G) strategies for clients—securing $550 million since 2007. We advance health and high-tech innovation for businesses and nonprofits by accessing non-dilutive funding, shaping policies and regulations, and building relationships with key decision-makers. Liz founded the Women's Health Advocates, which is in all 50 states and has organized the first-ever Women's Health Capitol Hill Day on May 21, 2025, the Breast Cancer Early Detection Coalition Hill Day on July 16, 2025, Congressional Briefings and online forums, advocacy letter-writing campaigns, the drafting of legislative language, and grassroots mobilization events across the country. Previously, she served as Legislative Director in Congress where she staffed the Congressional Caucus for Women's Issues, Armed Services Committee and Small Business Committee and served as a Policy Analyst for UK Parliament's Health Committee as well as congressional and presidential political campaign staff. She has received the Woman Entrepreneur of the Year Award and Women of Achievement Award and earned her MPH from Harvard, JD from George Washington, and BA from Colgate.

In this episode of The D Shift: Redefining Divorce And Beyond, host Mardi Winder-Adams is joined by expert Dr. Pamela J. Pine for a frank and sobering discussion on the lasting impact of family conflict and abuse on children. Drawing on Dr. Pamela J. Pine's decades of work in preventing and mitigating child sexual abuse and addressing adverse childhood experiences (ACEs), the conversation centers on how trauma in the home—whether high, moderate, or even low levels of conflict—can shape a child's development, mental health, and future wellbeing.The episode challenges misconceptions around domestic violence and explores the strong correlation between abuse in the home and lifelong consequences, including neurological damage, chronic health issues, and cycles of addiction. Mardi Winder-Adams and Dr. Pamela J. Pine underscore the importance of community awareness, intervention, and support, emphasizing that silence and secrecy can exacerbate harm.This episode offers not just statistics and facts, but critical guidance for parents and caregivers facing these difficult situations. It provides straightforward language for supporting children, highlights the dangers of staying “for the kids,” and urges listeners to recognize that being proactive and informed can break the cycle of trauma. For anyone seeking to understand, help, or heal, this conversation is both an urgent warning and a compassionate resource.About the Guest:Pamela J. Pine, PhD, MPH has been an international health, development, and communication professional throughout her adult life, supporting the lives of poor and otherwise underserved groups, with a two-decade specialty on preventing and mitigating child sexual abuse (CSA) and other adverse childhood experiences (ACEs). She is the Founder/Director of Stop the Silence® - A Department of the Institute on Violence, Abuse and Trauma (IVAT). She is also a professor, best-selling and award-winning author, and a multimedia artist, which she uses in her work to open hearts and minds.To connect with Dr. Pine:Website: https://www.ivatcenters.org/stop-the-silence, Website: https://www.drpamelajpine.com, Facebook: https://www.facebook.com/stopcsa, Facebook: https://www.facebook.com/DrPamelaJPine2/, Email: pamelap@ivatcenters.orgAbout the Host: Mardi Winder is an ICF and BCC Executive and Leadership Coach, Certified Divorce Transition Coach, Certified Divorce Specialist (CDS®) and a Credentialed Distinguished Mediator in Texas. She has worked with women in executive, entrepreneur, and leadership roles, navigating personal, life, and professional transitions. She is the founder of Positive Communication Systems, LLC, and host of Real Divorce Talks, a quarterly series designed to provide education and inspiration to women at all stages of divorce. Are you interested in learning more about your divorce priorities? Take the quiz "The Divorce Stress Test".Connect with Mardi on Social Media:Facebook - https://www.facebook.com/Divorcecoach4womenLinkedIn: https://www.linkedin.com/in/mardiwinderadams/Instagram: https://www.instagram.com/divorcecoach4women/Youtube: https://www.youtube.com/@divorcecoach4womenThanks for Listening!Thanks so much for listening to our podcast! If you enjoyed this episode and think that others could benefit from listening, please share it using the social media buttons on this page.Do you have feedback or questions about this episode? Leave a comment in the section below!Subscribe to the PodcastIf you would like to get automatic updates of new podcast episodes, you can subscribe to the podcast on Apple Podcasts. You can also subscribe in your favorite podcast app.Leave us an Apple Podcast ReviewRatings and reviews from our listeners are extremely...

Join Dr. Nicole and Hadlee as we sit down with Dr. K to explore what emotional health *really* means. He breaks down his simple yet powerful Five Pillars of Emotional Health-- and get ready-- these are going to be your next favorite tool for feeling calm, strong, happy and resilient! Today, ALL VIBES ARE WELCOME. Forget the pressure to "be happy" all the time- Dr. K shows us that the real goal is cultivating a sense of wonder and presence. This episode offers a fresh, grounded perspective and hands you the everyday strategies to gently bring your emotional life back into alignment. Dr. Karthik Ramanan is a licensed naturopathic physician, emotional health mentor, and passionate advocate for stress resilience. Known as The Emotional Health Mentor, he specializes in helping high-achieving professionals break free from stress, self-doubt, and burnout so they can live with purpose and confidence. With a background in engineering and business, Dr. Ramanan blends science, strategy, and compassion to guide individuals toward emotional freedom and lasting well-being. He is also a speaker and host of the “Rise Up with Dr. Ramanan” podcast, where he shares tools and inspiration for living an empowered life. Follow him on social media: https://www.drkarthikramanan.com/ https://www.instagram.com/dr.karthikramanan/?hl=en https://www.facebook.com/dr.karthikramanan/ Additional Resources:

When competitive eating champion meets dental hygiene student, you get a episode unlike any other. Matt Crespin welcomes Miki Sudo – an 11-time Nathan's Hot Dog Eating Contest champion who holds the world record of 51 hot dogs in 10 minutes and is preparing to graduate from the dental hygiene program at Hillsborough Community College in spring 2025. Miki shares her unexpected journey from professional competitive eater to future dental hygienist as she seeks long-term stability as a wife and mother. She opens up about entering the program with no dental experience, battling self-doubt and discovering genuine passion for the profession. From training with her husband (also a competitive eater) to being recognized by patients, Miki's story reveals determination behind balancing two demanding careers. Her advice: take things one step at a time and believe in your capabilities. Whether it's one hot dog or one chapter at a time – people are capable of amazing things.    Guest: Miki Sudo, Dental Hygiene Student, 11-time Nathan's Hot Dog Eating Contest Champion  Host: Matt Crespin, MPH, RDH, FADHA   https://majorleagueeating.com/eaters/222 https://www.youtube.com/watch?v=yePLRwc607Q https://www.youtube.com/watch?v=A1lvjSRNpwM

For this week's episode of the Clinician's Corner, we've gone into the archives to pull out another clinical pearl from one of our favorite episodes - and today we discuss the powerful healing properties of sulforaphane with David Roberts & Dr. John Gildea, from Mara Labs.   This interview first aired in 2023, and the full interview can be viewed here.   Clinical pearls we extracted from the original interview: The story behind BrocElite, a stabilized sulforaphane supplement The motivation behind the research  The scientific background on sulforaphane (e.g., its development and stabilization) How sulforaphane plays a role in cancer and chemotherapy  The Clinician's Corner is brought to you by the Institute of Restorative Health. Follow us: https://www.instagram.com/instituteofrestorativehealth/   Connect with Mara Labs: Website: https://mara-labs.com/ Instagram: https://www.instagram.com/themaralabs/?hl=en Facebook: https://www.facebook.com/themaralabs/    Speaker bios: David Roberts holds a MPH from Johns Hopkins, a Masters in BME from the UVA, and a Bachelors in EE and BME from Duke. David has more than 20 years of public health experience on three continents. In 2014 David cofounded the gut supplement, RESTORE, now called ION.    Dr. John Gildea is Cell Pathophysiologist and Molecular Geneticist with 33 years of scientific research experience at the bench in both industrial and academic labs.  A guiding principle of his work is to establish innovative optimized model systems and assays in order to robustly investigate both normal and pathological states. He has extensive expertise establishing and investigating in-vivo, ex-vivo, primary and immortalized cell culture systems, molecular biology, antibody based and nucleic acid based diagnostic assay development, electron and fluorescence microscopy and flow cytometry. Dr. Gildea has published 63 peer reviewed articles, 3 book chapters, 3 reviews, 3 patents, and has 3173 citations.    Keywords: functional health, sulforaphane, broccoli, breast cancer, oncology, chemosensitizer, glucoraphanin, myrosinase, supplement, restorative health, anti cancer, clinical skills, chronic disease, cancer models, NRF2, antioxidant system, chemotherapy, metastasis, Mara Labs, Baroque Elite, broccoli sprouts, juicing, practitioner training, case studies, gastrointestinal healing, functional medicine, curriculum, certification, clinical mastery, immune system, detoxification Disclaimer: The views expressed in the IRH Clinician's Corner series are those of the individual speakers and interviewees, and do not necessarily reflect the views of the Institute of Restorative Health, LLC. The Institute of Restorative Health, LLC does not specifically endorse or approve of any of the information or opinions expressed in the IRH Clinician's Corner series. The information and opinions expressed in the IRH Clinician's Corner series are for educational purposes only and should not be construed as medical advice. If you have any medical concerns, please consult with a qualified healthcare professional. The Institute of Restorative Health, LLC is not liable for any damages or injuries that may result from the use of the information or opinions expressed in the IRH Clinician's Corner series. By viewing or listening to this information, you agree to hold the Institute of Restorative Health, LLC harmless from any and all claims, demands, and causes of action arising out of or in connection with your participation. Thank you for your understanding.  

Rapid phenotypic antimicrobial susceptibility testing (AST) significantly reduces time to actionable results and can improve antibiotic decision-making for patients with bloodstream infections. Listen in to learn from Michael P. Veve, PharmD, MPH, how to optimally integrate rapid phenotypic AST into clinical practice, including incorporation into your existing antimicrobial stewardship workflow. Topics covered include:Considerations for implementationDecision-making steps for implementationThe role of antimicrobial stewardship programs in AST workflowPresenter:Michael P. Veve, PharmD, MPHClinical Associate ProfessorDepartment of Pharmacy PracticeEugene Applebaum College of Pharmacy and Health SciencesWayne State UniversityClinical Pharmacy Specialist, Infectious DiseaseHenry Ford HospitalDetroit, MichiganLink to full program and downloadable slides:https://bit.ly/4inoXCxGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Dr. Domenica Giovannini, a 2011 graduate of the Master of Public Health program at Touro University California, has built a career of community service on the foundation of her MPH degree and recently added “Doctor” to her list of professional accomplishments. Now she's giving back to her alma mater with service on the Alumni Association Board of Directors.

Joining host Mark Houston is Chad Storch, M.D., MPH, Occupational Medicine at Rapid City Clinic, Mount Rushmore Road. Dr. Storch shares his experiences of caring for sailors and marines aboard the USS Oak Hill and overseeing the health of over 1,500 aviators and air traffic controllers as Aviation Medicine Department Head at Naval Air Station Whiting Field. He also breaks down the importance of FAA physicals, what it takes to keep airmen safe to fly and discusses his work as a Civil Surgeon performing immigration medical examinations. Hosted on Acast. See acast.com/privacy for more information.

More than three million dental implants are placed annually. Hygienists can help protect implant longevity with biofilm control, advanced air polishing, and patient-centered care strategies. Amber Auger, MPH, RDH Read by Jackie Sanders https://www.rdhmag.com/patient-care/implant-maintenance/article/55311878/responsible-restorative-dentistry-creating-sustainable-protocols-for-implants

In many East Asian cultures, childbirth marks not just a beginning, but a sacred period of recovery known as Zuò Yuè Zi, or “sitting the month.” Rooted in Traditional Chinese Medicine, this postnatal confinement practice emphasizes rest, warmth, and nourishment to restore balance and vitality after delivery, which is said to deplete the mother's qi, or vital life force. In the modern and busy world of working mothers with unpaid maternity leave, is it possible to incorporate facets of an ancient rejuvenating practice into the home?In this episode, we are joined by Dr. Kristal Lau, MBBS, MPH, BMedSc. Dr. Lau is a board-certified physician with over a decade of experience, the leading postpartum wellness consultant, author of 'Postpartum 30' (double winner at the NYC Big Book Award), and the founder of Bridges in Health and Mama's Wing Woman, a consulting company that creates wellness experiences for individuals and families and provides postpartum planning, coaching, and wellness programs to new parents and their families.Dr. Lau received her MBBS from the University of Queensland in Brisbane, MPH in Health Care Organization and Policy from the University of Alabama at Birmingham, and General Medicine residency in Australia. Dr. Lau has then become an expert in postpartum practice, having served as an Advisor and the Co-Chair of the Women's Health Lifestyle Medicine Initiative at European Lifestyle Medicine Organization, Postnatal Retreat Development Consultant at Sanu, Family Resiliency Expert at the United States Army, and Director of Education at the Military Birth Resource Network & Postpartum Coalition. Dr. Lau has been featured on Goop, Medium, CEO Weekly, KTLA, Exeleon Magazine, EIN Presswire, and ABNewswire.Follow Friends of Franz Podcast: Website, Instagram, FacebookFollow Christian Franz (Host): Instagram, YouTube

A billion children. Millions of lives saved. And you've probably never heard the full story—until now.In this episode of the Public Health Insight Podcast, host Gordon sits down with Dr. Seth Berkley, the mastermind behind Gavi and author of "Fair Doses," to pull back the curtain on the alliance that quietly changed global health forever. From high-stakes decisions during the COVID-19 pandemic to the relentless pursuit of vaccine equity, this episode is packed with the real stories, hard lessons, and bold ideas that rarely make the headlines.References for Our Discussion◼️Fair Doses: An Insider's Story of the Pandemic and the Global Fight for Vaccine Equity◼️How children will be impacted by U.S. cuts to global vaccine alliance◼️The diseases that could return as vaccination rates decline — and why you should careGuest◼️Dr. Seth Berkley, MDHost & Producer(s)◼️ Gordon Thane, BMSc, MPH, PMP®Production Notes◼️ Music from Johnny Harris x Tom Fox: The Music RoomSubscribe to the NewsletterSubscribe to The Insight newsletter so you don't miss out on the latest podcast episodes, live events, job skills, learning opportunities, and other engaging professional development content here.Leave Us Some FeedbackIf you enjoy our podcasts, be sure to subscribe and leave us a rating on Apple Podcast or Spotify, and spread the word to your friends to help us get discovered by more people. You can also interact directly with the podcast episodes on Spotify using the new “comment” feature! We'd love to hear what you think.Send us a Text Message to let us know what you think.We're giving away a copy of Dr. Seth Berkley's new book, Fair Doses: An Insider's Story of the Pandemic and the Global Fight for Vaccine Equity. To enter, just send an email to ThePublicHealthInsight@gmail.com with "Book Giveaway" as the Subject Line. Entries close on November 26th and we'll reach out to the winner of the contest on November 27th. You must live in the U.S. to be able to participate. 

Desmintiendo el mito de que la gripe “es solo una gripe” La peligrosa realidad de la influenza en los niños Entrevista con: Imelda Reyes, DNP, MPH, CPNP-PC, FNP-BC, FAANP- Experta en pediatría y Enfermera Practicante Especializada en Pediatría  Conduce: Lilian Carbone

1. Zero - Holy Ghost 00:01:04 2. MPH x Habstrakt - Untouchable (Strangers Remix) 00:04:03 3. Hebbe - Spirit Dub 00:06:08 4. Host - Enter This World 00:09:20 5. TIMBALAND - THE WAY I ARE (COSTA FLIP) 00:11:35 6. Haven - I Run (CHOZEN Flip) 00:14:37 7. Himalia - Hellish 00:16:27 8. PONZ - Atmosphere 00:18:17 9. ColtCuts ft. Killa P - We Are DDD 00:20:34 10. Work - Lockerz Dub 00:22:10 11. Armand Van Helen - You Dont Know Me (DJ Jackum Party Garage Bootleg) 00:24:46 12. Disco Lines - Cocaine Inside My Blunts (SEVSKY Remix) 00:27:07 13. Distinct Motive x Ganja White Night - Bark Mode 00:29:52 14. Mala x Magugu - MILITANT DON 00:31:28 15. Yo Majesty - Club Action (Vulora Remix) 00:33:31 16. Bone Thugs & Harmony - Thuggish Ruggish Bone (HVRCRFT Flip) 00:35:19 17. Floret Loret - Lightsplinter 00:37:50 18. Floret Loret - Frenzy 00:40:57 19. Notorious B.I.G. - Big Poppa (ZURGLIN Flip) 00:44:35 20. Touch Sensitive - Before U Met My Body 00:46:53 21. Kill Safari - B2B2B 00:49:34 22. ÆON:MODE - RUN 00:51:09 23. Visionobi Vektah - Modus Operandi 00:53:38 24. CrucifyMe - Radiance 00:55:45 25. Smg - Lang 00:57:13

Podcast Family, we have covered the subject of Measles previously on this show (links below). Those episodes were a preview of what has now been released ahead of print as a narrative review in the Green Journal! In this episode, we will summarize the KEY points of measles infection in pregnancy and re-state the “rule of 4” and the importance of the number 10 regarding this.1. Feb 24, 2025: Measles 101: https://open.spotify.com/episode/4lXrpqKTJPdDcTXPxpEmcb2. April 27, 2019: Measles!! ACOG Practice Advisory: https://creators.spotify.com/pod/profile/dr-hector-chapa/episodes/MEASLES---ACOG-practice-advisory-e3s1p43. Joseph, Naima T. MD, MPH. Measles in Pregnancy: Clinical Considerations and Challenges. Obstetrics & Gynecology ():10.1097/AOG.0000000000006126, November 14, 2025. | DOI: 10.1097/AOG.0000000000006126

For this episode, the Activist Lab welcomes our guests, Nazneen Pal and Aria Garling, public health advocates who also serve on the Florida Let's Chat taskforce.  These public health professionals discuss the topics of loneliness and social isolation, reasons for the increase- especially among the younger generation, and strategies for change, including the work of the Health Buddies program (Seniors in Service) and more!   Guest:  Let's Chat taskforce members Aria Garling, BA, Program Manager, Seniors in Service Program of Tampa Bay; and Nazneen Pal, MPH, Public Health Practitioner

Earlier this month, more than 2,500 allergists and healthcare professionals gathered in Orlando, Florida, for the annual meeting of the American College of Allergy, Asthma & Immunology—better known as ACAAI. It's one of the biggest events of the year where experts share the latest research, treatments, and guidelines in allergy and immunology. We're thrilled to be joined by this year's keynote speaker, program chair—and FAACT Medical Board Member—Dr. Kristin Sokol, MD, MS, MPH, who shares highlights and key takeaways from this cutting-edge meeting.Resources to keep you in the know:American College of Allergy Asthma and Immunology (ACAAI)Schreiber Allergy: Kristin Sokol, M.D., MS, MPH, FACAAI, FAAAAIYou can find FAACT's Roundtable Podcast on Apple Podcasts, Pandora, Spotify, Podbay, iHeart Radio, or wherever you listen to podcasts.Follow us on Facebook, Instagram, BlueSky, Threads, LinkedIn, Pinterest, TikTok, and YouTube.Sponsored by: GenentechThanks for listening! FAACT invites you to discover more exciting food allergy resources at FoodAllergyAwareness.org!

Fantasy Baseball Live – November 16, 2025 – 3:00 pmMicrosoft Teams:Segment 1 – Finish up the AL Central Prospects – Out on Wednesday•Kansas City Royals•Minnesota TwinsSegment 2 – News and NotesWhere will they sign?1.Kyle Tucker (OF, CHC, Excel)a.Tim and Rich – both LAD2.Bo Bichette (2B, Tor, VanyerSports)a.Tim – Braves and Rich – Blue Jays3.Cody Bellinger (OF, NYY, Boras)a.Tim – NYY and Rich - Cardinals4.Alex Bregman (3B, Bos, Boras)a.Tim – Tigers and Rich - Phillies 5.Framber Valdez (LHP, Hou, Octagon)a.Tim – Giants and Tim – Red Sox6.Ranger Suarez (LHP, Phi, Boras)a.Tim – Cubs and Rich - Orioles7.Pete Alonso (1B, NYM, Boras)a.Tim – Padres and Rich - Mets8.Kyle Schwarber (DH, Phi, Excel)a.Tim and Rich - Phillies9.Dylan Cease (RHP, SD, Boras)a.Tim – Red Sox and Rich - Cubs10.Munetaka Murakami (3B/1B, NPB, Excel)a.Tim – Mariners and Rich - NYY11.Josh Naylor (1B, Sea, ISE Baseball)a.Tim – Mets and Rich - Angels12.Tatsuya Imai (RHP, NPD, Boras)a.Tim – Blue Jays and Rich - NYYSegment 3 – Fantasy Questions of the NL East – BravesAtlanta Braves1.After 39 drafts in the NFBC, Ronald Acuna's ADP is 9.87 (10th pick). Two knee surgeries in three years, and he stole 9 bases in 95 games in 2025. He's still a great player, but is he worth the 10th overall pick in a draft?a.Tim says no.2.Austin Riley hit 36 home runs in 2022, 37 in 2023. Then, 19 in 2024 and 16 last season. He was hurt, but still played in 102 games in 2025. Over/Under 30 home runs for Austin Riley in 2026? - Overa.The bat speed and exit velocities still appear intact – 92.3 MPH exit velo.b.His ADP is 68 or the fifth round. Does that feel about right or too high, too low?i.Tim - Too low, but you're going to pass and wait on third base.3.I've been down on Ozzie Albies for several years, as I didn't believe in the power. He just doesn't hit the ball hard and gets his home run power through leverage. His speed has fallen now, with just 14 stolen bases (44th percentile in sprint speed).a.2026 stat line – HR, SB, and BA – 17 HR, 13 SB, .245b.His ADP is 158 or 11th round – ninth overall second baseman. Is there value there?4.If you had an early NFBC draft and hold, who would you draft as their closer?a.Joe Jimenez and Grant Holmes5.Give me a sleeper in the organization (minor or majors)a.Hurston WaldrepClose

In this episode, Lindsay Myers, MBA, MPH, Vice President of Revenue Cycle and HIM at Chapters Health System, discusses how her organization is scaling operations, leveraging automation, and investing in people to support rapid growth and long-term financial stability across its nationwide hospice and value-based care network.

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, "NEALS 2025: Takeaways That Matter for ALS Care," ALS experts Jinsy Andrews, MD, MSc, and James Berry, MD, MPH, reflect on key themes from the 2025 NEALS Annual Meeting, now reintroduced as the Network of Excellence for ALS. They discuss format changes that elevated lightning science, the expanding gene therapy pipeline, and a growing slate of NEALS-affiliated trials. The conversation highlights updates from the HEALEY Platform Trial, the MY-MATCH biomarker-guided precision trial, SOD1 program data, and new antisense and viral vector therapies aimed at sporadic ALS. They also explore the impact of Act for ALS on trial access, the ALL ALS biospecimen repository, and NIH-supported expanded access cohorts. The discussion closes with insights on combination therapy strategies, genetic subtypes, presymptomatic enrollment, and how new collaborations, digital endpoints, and infrastructure advances are shaping momentum heading into 2026. Looking for more Neuromuscular discussion? Check out the NeurologyLive® Neuromuscular clinical focus page. Episode Breakdown: 1:05 – Reflections on meeting highlights and NEALS rebranding into a global network 5:00 – Notable NEALS-affiliated trials and promising new mechanisms in ALS care 12:45 – Combination therapy strategies and future approaches in ALS research 15:20 – Neurology News Minute 18:00 – Expanding clinical trial access for rare and genetic ALS subtypes 22:10 – Building momentum and expectations for the 2026 NEALS Annual Meeting The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: FDA Approves Doxecitine and Doxribtimine Combination Therapy as First Treatment for Thymidine Kinase 2 Deficiency Supplemental New Drug Application Submitted for AXS-05 as Treatment for Alzheimer Disease Agitation BTK Inhibitor Fenebrutinib Meets Primary End Points in Phase 3 Trials for Both Relapsing and Primary Progressive MS  Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Gut Health with Dr. Wendy Holland In this episode, Dr. Wendy Holland, DNP, MPH, FNP-BC, APRN, opens up about all things "gut health" related! She takes us a journey through the windy complexities of this complicated topic! She offers listeners tools and tips to care for your gut health, dispels myths and misinformation and breaks down why gut health is so important. She also sheds light on prebiotics, probiotics and the microbiome! Her insight and wisdom on this topic are vast and provide context to the gut-brain connection! Connecting with Dr. Wendy Holland: Website – www.laic.net Facebook page - https://www.facebook.com/profile.php?id=61557425495508   LinkedIn - https://www.linkedin.com/in/wendy-holland-dnp-mph-fnp-bc-arnp-8a1405186/    Connect with She Wise Wellness: Website: https://www.shewisewellness.com/ Website: www.shewisepublications.com Email: shewisepublications@gmail.com Instagram: https://www.instagram.com/she_wise_publications/ https://www.facebook.com/profile.php?id=100094044723450 YouTube: SHE Wise @survivingthehumanexperience https://www.youtube.com/channel/UCtYaqS-cL1WAFQKDadapxPQ

Get insights on digital transformation and the future of clinician-centered AI with Ed Lee, MD, MPH, chief medical officer at Nabla.

Mapping the Landscape of Technical Standards: A Nationwide Review of Medical Schools Interviewees: Carol Haywood, PhD, OTR/L — Assistant Professor, Medical Social Sciences, Northwestern University Feinberg School of Medicine Chris Moreland, MD, MPH — Professor of Internal Medicine; Division Chief for Hospital Medicine; Interim Associate Chair for Faculty Affairs and Development, Dell Medical School (Comments made in ASL and voiced through interpreters) Interviewer: Lisa Meeks, PhD, MA — Guest Editor, Academic Medicine Supplement on Disability Inclusion in Undergraduate Medical Education Description: In this episode of Stories Behind the Science, we sit down with Dr. Carol Haywood and Dr. Chris Moreland to explore a deceptively powerful document: the medical school technical standards. These quietly influential statements—often tucked deep in an admissions webpage—shape who feels welcome to apply, who gains access, and how institutions imagine the future of their profession. Haywood and Moreland, co-authors of a national analysis featured in the Academic Medicine supplement on Disability Inclusion in Undergraduate Medical Education, unpack what happens when ambiguous language, outdated assumptions, and vague expectations collide with real people making real decisions about their careers. Together, they dig into the nuances of functional vs. organic standards, the importance of clarity for applicants who lack insider knowledge, and the ripple effects of inequitable policies across a learner's entire training experience. What emerges is both sobering and hopeful: a field undergoing change, a growing recognition that words matter, and a roadmap for institutions ready to bring their values into alignment with their practices. The discussion reviews: How technical standards became a gatekeeper—and why revising a single sentence can shift an entire culture. Why students with disabilities read these documents differently—and why that matters for equity. How ambiguity in admissions can deter talented future physicians long before they step foot in a classroom. What schools can do now to create standards that prioritize competence, flexibility, and inclusion. Dr. Haywood brings a researcher's lens and an occupational therapist's creativity to the conversation, illuminating how functional expectations—not assumptions about bodies—should guide medical training. Dr. Moreland shares deeply personal reflections on navigating technical standards as a deaf physician, offering rare insight into how these documents land on applicants with lived experience. This episode invites the audience to imagine a medical education landscape where technical standards do what they should do—define competence, set expectations, and open doors—rather than unintentionally closing them. Bios:  Carol Haywood, PhD, OTR/L, is Assistant Professor of Medical Social Sciences in the Determinants of Health Division and core faculty in the Center for Health Services and Outcomes Research at Northwestern University Feinberg School of Medicine in Chicago, IL. Building from her work as an occupational therapist in acute rehabilitation, she completed a PhD in occupational science at the University of Southern California and a postdoctoral fellowship in health services and outcomes research at Northwestern University. Using qualitative, mixed methods, and community-engaged research approaches, she studies disability in a variety of contexts, as well as health care access, coordination, and quality. She is driven by a vision of health care that facilitates equity for people with disabilities. Chris Moreland, MD MPH, is a professor of medicine, interim associate department chair for faculty affairs, and division chief for hospital medicine at Dell Medical School at UT Austin. He practices clinically as a hospitalist. As a career-long clinician educator, his teaching has been recognized regionally and nationally. His collaborative advocacy and research efforts describe the experiences of our healthcare workforce and learners with disabilities, as well as strategies to foster pathways to thriving clinicians. He has served as president and longtime board member for the Association of Medical Professionals with Hearing Losses; he holds current roles on the Docs with Disabilities Initiative advisory board, the AAMC Group on Diversity and Inclusion steering committee, and as a consultant with the National Deaf Center. Transcript: https://docs.google.com/document/d/18hUPguWf_jWeDC1fmOgSKSXPv4xGnkQIPUi3zhfH540/edit?usp=sharing Resources: Singer, Tracey; Madanguit, Lance MD; Fok, King T. MD, MSc; Stauffer, Catherine E. MD; Meeks, Lisa M. PhD, MA; Moreland, Christopher J. MD, MPH; Huang, Lynn MS; Case, Benjamin MPH; Lagu, Tara MD, MPH; Kannam, Allison MD; Haywood, Carol PhD, OTR/L. Mapping the Landscape of Technical Standards: A Nationwide Review of Medical Schools. Academic Medicine 100(10S):p S144-S151, October 2025. | DOI: 10.1097/ACM.0000000000006135   McKee, M.M., Gay, S., Ailey, S., Meeks, L.M. (2020). Technical Standards. In: Meeks, L., Neal-Boylan, L. (eds) Disability as Diversity. Springer, Cham. https://doi.org/10.1007/978-3-030-46187-4_9 Equal Access for Students with Disabilities: The Guide for Health Science and Professional Education (2nd Ed). Meeks LM, Jain NR, & Laird EP. Springer Publishing, 2020. Key Words: Disability inclusion · Technical standards · Medical education · Admissions · Accessibility · Equity · Policy reform

Join host and Digital Education Committee Member Sandeep A Saha, MD, MS, FHRS for this lively discussion with his colleagues Charles A. Henrikson, MD, MPH, FHRS and Arun R. Mahankali Sridhar, MBBS, MPH, FACC. About this Article: In patients with symptomatic premature ventricular complexes (PVCs) refractory to medical therapy, non-invasive low-level tragus stimulation of the auricular branch of the vagus nerve significantly reduced median PVC burden compared to sham stimulation (median reduction ~13.4% vs ~8.6%; P = 0.021). The findings suggest that autonomic neuromodulation via transcutaneous vagal stimulation may offer a novel adjunctive therapy for frequent PVCs, although further larger trials are needed to evaluate long-term outcomes. Learning Objectives Describe the rationale and mechanism by which transcutaneous vagus nerve stimulation (tVNS) may modulate autonomic tone and reduce premature ventricular contractions. Summarize the design, methods, and key outcomes of the NoVa-PVC randomized crossover trial evaluating tVNS for symptomatic PVC reduction. Evaluate the clinical implications, limitations, and potential future applications of noninvasive neuromodulation as a therapeutic approach for ventricular arrhythmias. Article Authors Stefanos Zafeiropoulos MD, MBA, Kristie Coleman MPH, RN, Jonathan Kogan,Dimitrios Varrias MD, Jonas Leavitt BS, Alexandra Bekiaridou MD, Theodoros Zanos PhD, Stavros Zanos PhD, MD, Stavros Stavrakis PhD, MD, Stavros Mountantonakis MD, MBA  Podcast Contributors Sandeep A Saha, MD, MS, FHRS Charles A. Henrikson, MD, MPH, FHRS Arun R. Mahankali Sridhar, MBBS, MPH, FACC  All relevant financial relationships have been mitigated. Host Disclosure(s): S. Saha •Speaking/Teaching/Consulting: Medtronic   ​Contributor Disclosure(s):    C. Henrikson •Honoraria/Speaking/Teaching/Consulting: American College of Cardiology A. Sridhar •Nothing to disclose.   Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner): S. Sailor: No relevant financial relationships with ineligible companies to disclose.

We have tales of why nothing good happens after midnight in the Ill-Advised News. One, of two teenagers bored and causing $160,000 of damage, and another of a woman driving 107 MPH for pizza. We discuss the departure of the penny, first loves, more Ill-Advised News, and get Zahn-y with it. Support the show and follow us here Twitter, Insta, Apple, Amazon, Spotify and the Edge! See omnystudio.com/listener for privacy information.

In this powerful episode of the Functionally Enlightened Podcast, Dr. Sharon Surita, PhD, BCFDNP sits down with Sally K. Norton, MPH, nutrition expert, public health researcher, and author of Toxic Superfoods: How Oxalate Overload is Making You Sick—and How to Get Better.Sally holds a nutrition degree from Cornell University and a Master's in Public Health, and her career has spanned major medical schools in medical education and public health research. After years of personal health struggles, Sally discovered the devastating effects of dietary oxalates — plant compounds found in many popular “superfoods” like spinach, almonds, sweet potatoes, and beets.In this conversation, Sharon and Sally explore how oxalates may be the missing link in chronic illness, autoimmunity, and implant-related inflammation, offering life-changing insights for anyone struggling with unexplained fatigue, pain, or inflammatory symptoms.

About Dr. Julie Schulz:Dr. Julie Schulz, MD, MPH, is a physician executive and product leader based in Los Angeles with a proven track record of driving innovation at the intersection of healthcare, technology, and business. Over the past 15 years, she has built and led teams developing healthcare decision support, analytics, and consumer health products across value-based care, women's health, and life sciences. As VP of Product at Avalon Healthcare Solutions, she leads strategy for next-generation diagnostics platforms. Previously, at HALO Diagnostics and Doctor Evidence, she guided product and business development efforts that integrated imaging, laboratory, and evidence-based analytics to improve patient and physician experiences. Earlier roles at Lumere and Sg2 honed her expertise in clinical data, product-market fit, and scaling evidence-driven solutions. Published in leading journals, Dr. Schulz combines deep clinical insight with strategic leadership to advance innovations that improve healthcare outcomes and drive measurable business impact.Things You'll Learn:Diagnostic intelligence can transform diagnostics from a cost center into a strategic asset that improves quality and lowers costs.Physicians face overwhelming volumes of new tests and guidelines, and AI-powered decision support can ease their cognitive burden.By removing prior authorization barriers, patients can transition from diagnosis to treatment in just 15 days, rather than the typical 60 days.Data shows that healthier patients are more likely to receive GLP-1 prescriptions, revealing a need for better risk-adjusted care strategies.True innovation in healthcare depends on communication, simplifying complexity and aligning clinicians, payers, and technologists toward shared goals.Resources:Connect with and follow Dr. Julie Schulz on LinkedIn.Follow Avalon Healthcare Solutions on LinkedIn and explore their website.Read Avalon Healthcare Solutions' Annual Lab Trend Report here.

The federal process for approving and recommending seasonal respiratory vaccines deviated from the typical schedule this year. That led to confusion about who is eligible for Covid vaccines and delayed shipping and distribution of the shots.This week, Jeanna Miller and Sara Heineman from Missoula Public Health joined the commissioners to unpack how all of this happened and how the Immunization Clinic at MPH is here to help. They also discuss what they learned from the health department's recent countywide vaccine access and barrier report. Text us your thoughts and comments on this episode! Thank you to Missoula's Community Media Resource for podcast recording support!

Iron isn't just important for us – viruses need it too. Katherine Wander, associate professor of anthropology at Binghamton University, examines how this plays a role in COVID infections. Kathy Wander is a biological anthropologist in Binghamton University's department of Anthropology. She received her BA from the Ohio State University and her MPH and PhD […]

Julia Kaset, MPH, RDN, is a nutritional and lifestyle coach at Nutrition World — but she's so much more than that. In this episode, we dive into our complex relationship with food — from performance and disease prevention to aging and eating disorders. Despite her young age, Julia's education and personal journey have uniquely equipped her to guide others toward a healthier mindset around food. A former college athlete, she once hid her own struggles until realizing that true freedom with food required a complete shift in perspective. Now, she uses her experience and expertise to help others build balanced, empowering relationships with nutrition and performance. ===== THANK YOU TO OUR SPONSORS: Nutrition World: https://nutritionw.com/ Vascular Institute of Chattanooga: https://www.vascularinstituteofchattanooga.com/ The Barn Nursery: https://www.barnnursery.com/ Optimize U Chattanooga: https://optimizeunow.com/chattanooga/ Guardian Investment Advisors: https://giaplantoday.com/ Alchemy Medspa and Wellness Center: http://www.alchemychattanooga.com/ Our House Studio: https://ourhousestudiosinc.com/ ALL THINGS JEFF STYLES: www.thejeffstyles.com PART OF THE NOOGA PODCAST NETWORK: www.noogapodcasts.com Please consider leaving us a review on Apple and giving us a share to your friends! This podcast is powered by ZenCast.fm

In this SolFul Connections podcast episode, Amanda talks with Beatriz Victoria Albina, MPH, NP, author of End Emotional Outsourcing, about what it means to reclaim your emotional autonomy.Beatriz shares how so many of us unknowingly give away our emotional power seeking validation, peace, or self-worth from others, and how we can begin to take it back.If you've ever struggled with people-pleasing, perfectionism, or the need for external approval, this episode offers a compassionate framework for finding your way back to yourself.For more: Book Launch - End Emotional Outsourcing - Beatriz Victoria Albina

Omari Richins, MPH of Public Health Careers podcast talks with Brittaney Jenkins, BS, CHES. In this episode, Public Health Consultant and CEO of Jenkins Public Health Consulting, Brittaney Jenkins, BS, CHES, shares her 20-year journey from local health educator to entrepreneur.She dives into the importance of chronic disease prevention, how mindset and mentorship shape career growth, and why nonprofits can offer stable, impactful opportunities. Brittaney also opens up about balancing motherhood, leadership, and purpose-driven work.Tune in for actionable advice on career advancement, consulting, and creating meaningful impact in public health.

From his early days as a Peace Corps volunteer in Benin to leading the world's first clinical trial of an mRNA-based malaria vaccine, Matthew Laurens, MD, MPH's, career journey in global health highlights how a passion for service can lead to transformative global impact.

In this episode, Dr. Jillian Lampert shares her extensive experience in the field of eating disorders, discussing the complexities of neurodivergent conditions such as ADHD and autism. The conversation explores the neurobiology behind eating disorders, the importance of understanding the brain-body connection, and the significance of seeking help. Dr. Lampert emphasizes that eating disorders are not merely behavioral issues but are deeply rooted in brain function and emotional responses. The episode also highlights the importance of recognizing red flags, developing coping mechanisms, and understanding the impact of societal messages on our relationship with food.TakeawaysEating disorders can manifest as both under-eating and overeating.Neurobiology plays a crucial role in understanding eating disorders.Picky eating can be a sign of an eating disorder, especially in children.Willpower is not the solution to eating disorders; it's about brain function.The brain-body connection is vital in managing eating habits.Establishing a routine can help regulate eating patterns.Red flags for eating disorders include impulsivity and dissatisfaction with body image.Seeking help is essential for recovery from eating disorders.Coping mechanisms and support systems are crucial for managing eating behaviors.Food can act as a drug, triggering emotional responses and cravings.Dyslexia, ADHD, autism, eating disorders, neurodivergent, mental health, nutrition, recovery, support, awareness, adults with dyslexia, support for adults.DR. Jillian Lampert: PhD, MPH, RD, LD, FAED, Vice President of Strategy and Public AffairsCompany Website:https://emilyprogram.com/about-us/leadership-team/jillian-lampert/Jillian L's LinkedIn: https://www.linkedin.com/in/jillian-lampert-2a735651/Company LI - https://www.linkedin.com/company/the-emily-program/_______________________________Join the clubrightbrainresetters.comGet 20% off your first orderhttps://addednutrition.comIf you want to find out more visit:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠truthaboutdyslexia.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Join our Facebook Group⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠facebook.com/groups/adultdyslexia⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

In this episode of Take the Stage, Brad Bialy sits down with Lia Taniguchi to unpack Bullhorn's 2025 Grid Talent Trends Report and explore how data, AI, and human connection are reshaping the candidate experience in staffing and recruiting. About the Guest Lia Taniguchi is the Senior Research Manager at Bullhorn, leading global market research that drives data-informed strategy for the staffing industry. With an MBA from Simmons College and a forthcoming MPH from Boston University, Lia brings a rare mix of analytical depth and human-centered insight to her work. Key Takeaways Only 26% of Gen Z candidates are actively using a recruiter—showing an urgent need for better engagement and support for younger talent. 54% of candidates stopped working with a recruiter due to slow or unclear communication, proving that speed and transparency are now table stakes. 88% of candidates rated their voice agent interview as as good as or better than speaking with a person, signaling growing comfort with AI-driven screening. Overall candidate satisfaction declined across every stage of the recruitment process in the past year, with speed and responsiveness dropping by 20%. Candidates want instant acknowledgment—most expect confirmation within minutes and status updates within one week, mirroring Amazon-style service expectations. Timestamps [00:45] – Introducing the Grid 2025 Talent Trends Report [03:20] – Why Gen Z is least satisfied with recruiters [06:30] – Setting higher expectations in a digital-native world [10:25] – The power of intergenerational mentorship in recruiting [13:40] – Can AI fix the application black hole? [17:10] – What candidates really mean by “speed and communication” [20:15] – Remembering the human impact behind every resume [24:00] – Using AI to give feedback to the “silver medalists” [28:15] – 88% of candidates rate voice agents as good as people [33:20] – Why candidate satisfaction is declining—and how to fix it [37:45] – Secret shopping your own candidate experience [46:20] – Specialization as the new superpower for staffing firms About the Host Brad Bialy is a trusted voice and highly sought-after speaker in the staffing and recruiting industry, known for helping firms grow through integrated marketing, sales, and recruiting strategies. With over 13 years at Haley Marketing and a proven track record guiding hundreds of firms, Brad brings deep expertise and a fresh, actionable perspective to every engagement. He's the host of Take the Stage and InSights, two of the staffing industry's leading podcasts with more than 200,000 downloads. Sponsors and Offers Heard Take the Stage is presented by Haley Marketing. The old way of selling staffing is dead. Let's fix it—with smarter strategies and HUGE DISCOUNTS on modern lead-gen tools: https://bit.ly/Bialy20 Book a 30-minute business and marketing consultation with host, Brad Bialy: https://bit.ly/Bialy30 For 30 years, Benefits in a Card has delivered benefit plans designed specifically for the staffing industry—over 140 unique options with immediate coverage, unique perks like FreeRx, and solutions that reduce turnover while improving ACA compliance. Give your workforce benefits they'll actually use and give your staffing firm a competitive edge. Learn more at https://www.BenefitsInACard.com

Fantasy Baseball Live – November 9, 2025 – 3:00 pmMicrosoft Teams:Segment 1 – News and Notes1.Munetaka Murakami was officially posted over the weekend and has 45 days to sign.a.Give us a scouting reportb.Where are the best landing spots for him?2.The Rockies change leadership at the top, bringing in long-time executive Paul DePosta, who most recently was head of strategy for the Cleveland Browns of the NFL. I got to know him a bit in that role, and he's a super-smart, thoughtful guy, but I worry the Rockies are a “bridge too far” for anyone.a.Your thoughts?3.The Rays decline the $11 million option on Pete Fairbanks, and he is now a free agent.a.Of course they did. Fairbanks was solid, bordering on elite in 2025, with 27 saves and a 2.83 ERA.i.Who does he sign with?ii.And more importantly, who is the closer in Tampa?4.Shane Bieber surprises by exercising his option, staying with the Blue Jays.a.He turned down a huge payday to stay with the Blue Jays. Is there a long-term deal in the making?5.Trevor Story is staying put in Bostona.After his huge season in 2025, where he hit 25 home runs and stole 31 bases, is he a safe bet for a number #1 shortstop in 2026, or are you going to bypass him in drafts given his injury history?6.The Orioles acquire Andrew Kittredge, and I'm assuming he will be their closer with Felix Bautista missing the 2026 season.a.He's a Top _____________ closer for you in 2026Segment 2 – Fantasy Questions of the AL Central – Tigers, Royals, and TwinsDetroit Tigers1.When do we see Kevin McGonigle? – July 15a.Stat line for 2026 – AB, HR, BA – 240 AB, 10 HR, .265 BA2.Spencer Torkelson has had 31 home runs in the past three years, with a 10-home-run clunker in the middle. The even/odd theory says expect a tough season. The data says he has above-average exit velo, but a huge leverage swing to reach his power, and too many strikeouts (26%).a.What say you?3.Casey Mize finally had a solid season after going 1:1 in 2018. He posted a 3.87 ERA (xERA 3.69) but with only an 8.4 strikeout rate. a.Mize is a top ___________ pitcher.b.Where will you be interested if he falls in drafts, or will you?4.Will Vest get at least 25 saves next season – true or false?5.Give me a sleeper in the organization (minor or majors)Kansas City Royals1.Bobby Witt hit the ball harder in 2025 with an elite exit velo of 93.3 MPH with the same launch angle, yet he only hit 23 home runs. That makes no sense to me.a.I'm expecting 30+ home runs next season. What say you?2.Carter Jensen is my #1 prospect in the Royals system. Sal Perez is on a team-friendly 13.5 million contract extension. How many at-bats do you see Jensen getting?a.Is he someone who interests you?3.Jack Caglianonea.Stat line for 2026 – AB, HR, BA – 32 HRs, .195 BA4.Cole Ragans didn't live up to his lofty draft slot, but also spent three months on the IL. He still managed to strike out 98 in 61.2 innings. Do you still see him as #1 pitcher? Do you think you can get a discount on him at the draft table?5.Give me a sleeper in the organization (minor or majors)Minnesota Twins1.True or False - Byron Buxton will be over-drafted in 2026?2.Royce Lewis somewhat stayed healthy – playing in a career high 106 games. The power wasn't there though as he only hit 13 home runs and a .388 SLG. He still hits the ball hard enough with plenty of loft to project at least 20 to 25 home runs.a.Do we see a bit of a bounce back?b.Does it matter because we know he's going to get hurt?3.Pablo Lopez has two years remaining on his four-year deal with $21.75 million per season. Is he a Twin to start the season?a.If not, where does he go?4.Zebby Matthews – sigha.Stat line for 2026 – IP, wins, K's, and ERA.5.Give me a sleeper in the organization (minor or majors)Close